Zurich Cantonal Bank
AKCA

Zurich Cantonal Bank’s Akcea Therapeutics Inc AKCA Stock Holding History

Zurich Cantonal Bank’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,579
Closed -$47K – 2664
2020
Q3 		$47K Hold
2,579
– – ﹤0.01% 2272
2020
Q2 		$35K Buy
2,579
+2,080
+417% +$32.1K ﹤0.01% 2317
2020
Q1 		$7K Hold
499
– – ﹤0.01% 2533
2019
Q4 		$8K Sell
499
-900
-64% -$16.7K ﹤0.01% 2579
2019
Q3 		$22K Hold
1,399
– – ﹤0.01% 2441
2019
Q2 		$33K Sell
1,399
-2,301
-62% -$56.8K ﹤0.01% 2290
2019
Q1 		$105K Hold
3,700
– – ﹤0.01% 1557
2018
Q4 		$112K Sell
3,700
-600
-14% -$16.8K ﹤0.01% 1545
2018
Q3 		$151K Hold
4,300
– – ﹤0.01% 1467
2018
Q2 		$102K Hold
4,300
– – ﹤0.01% 1635
2018
Q1 		$110K Sell
4,300
-2,200
-34% -$47.4K ﹤0.01% 1542
2017
Q4 		$113K Hold
6,500
– – ﹤0.01% 1503
2017
Q3 		$180K Buy
+6,500
New +$120K ﹤0.01% 1058

Zurich Cantonal Bank's AKCA Position: Q4 2020 in Review

Zurich Cantonal Bank sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 2,579 shares — an estimated $47K sold.

Zurich Cantonal Bank first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $180K in Q3 2017. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Zurich Cantonal Bank reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Zurich Cantonal Bank sold 2,579 Akcea Therapeutics Inc shares in Q4 2020, an estimated $47K.
  • Zurich Cantonal Bank first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
  • Zurich Cantonal Bank's Akcea Therapeutics Inc position peaked at $180K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Zurich Cantonal Bank's 13F filing for Q4 2020, filed 28 Jan 2021.